{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T12:04:39Z","timestamp":1753877079733,"version":"3.41.2"},"reference-count":22,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2020,5,19]],"date-time":"2020-05-19T00:00:00Z","timestamp":1589846400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Paratek Pharmaceuticals"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Omadacycline, an aminomethylcycline, was approved in 2018 for the treatment of acute bacterial skin and skin structure infections and community-acquired bacterial pneumonia. In a Phase Ib study, around 34% of the absorbed dose of omadacycline was shown to be excreted in urine\u2014an important property for urinary tract infection (UTI) treatment. Therefore, omadacycline has been studied in two Phase II trials for the treatment of uncomplicated UTIs and acute pyelonephritis. The activity of omadacycline against UTI pathogens in human urine is important to understand in this context.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>To study the in vitro activity of omadacycline against UTI pathogens in human urine supplemented with calcium and magnesium.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Omadacycline activity was compared with that of levofloxacin against the urinary pathogens Escherichia coli, Klebsiella pneumoniae and Staphylococcus saprophyticus in standard medium, pooled normal human urine and neutral pH-adjusted pooled normal human urine spiked with calcium or magnesium at concentrations consistent with hypercalcaemia and hypermagnesaemia.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>The activities of omadacycline and levofloxacin against these urinary pathogens were lower in urine relative to standard medium; addition of Mg2+ to broth and urine had a further negative impact on omadacycline activity, whereas the addition of Ca2+ had less of an impact. Levofloxacin activity was not substantially reduced in either broth or urine by the addition of divalent cations.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>The activity of omadacycline against UTI organisms was lower in urine relative to standard medium and was negatively impacted by magnesium. Omadacycline displayed slightly reduced activity when excess calcium was present, but, overall, the differences were \u22642-fold. These observations should be considered along with the pharmacokinetics of the agent for clinical context.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/jac\/dkaa138","type":"journal-article","created":{"date-parts":[[2020,3,25]],"date-time":"2020-03-25T20:09:35Z","timestamp":1585166975000},"source":"Crossref","is-referenced-by-count":0,"title":["In vitro activity of omadacycline and levofloxacin against Escherichia coli, Klebsiella pneumoniae and Staphylococcus saprophyticus in human urine supplemented with calcium and magnesium"],"prefix":"10.1093","author":[{"given":"Paul","family":"Pagano","sequence":"first","affiliation":[{"name":"Micromyx, Inc., Kalamazoo, MI, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Marra","sequence":"first","affiliation":[{"name":"Micromyx, Inc., Kalamazoo, MI, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dean","family":"Shinabarger","sequence":"first","affiliation":[{"name":"Micromyx, Inc., Kalamazoo, MI, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chris","family":"Pillar","sequence":"first","affiliation":[{"name":"Micromyx, Inc., Kalamazoo, MI, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2020,5,19]]},"reference":[{"key":"2020051911581117800_dkaa138-B1","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.idc.2017.07.002","article-title":"Urinary tract infection and asymptomatic bacteriuria in older adults","volume":"31","author":"Cortes-Penfield","year":"2017","journal-title":"Infect Dis Clin North Am"},{"key":"2020051911581117800_dkaa138-B2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.idc.2013.09.003","article-title":"Urinary tract infection syndromes: occurrence, recurrence, bacteriology, risk factors, and disease burden","volume":"28","author":"Foxman","year":"2014","journal-title":"Infect Dis Clin North Am"},{"key":"2020051911581117800_dkaa138-B3","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1086\/671740","article-title":"Secular trends in Gram-negative resistance among urinary tract infection hospitalizations in the United States, 2000\u20132009","volume":"34","author":"Zilberberg","year":"2013","journal-title":"Infect Control Hosp Epidemiol"},{"key":"2020051911581117800_dkaa138-B4","doi-asserted-by":"crossref","first-page":"e02083","DOI":"10.1128\/AAC.02083-18","article-title":"Pharmacokinetics, safety, and clinical outcomes of omadacycline in women with cystitis: results from a phase 1b study","volume":"63","author":"Overcash","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"year":"2019","key":"2020051911581117800_dkaa138-B5"},{"key":"2020051911581117800_dkaa138-B6","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.diagmicrobio.2018.01.019","article-title":"Activity of omadacycline tested against Enterobacteriaceae causing urinary tract infections from a global surveillance program (2014","volume":"91","author":"Pfaller","year":"2018","journal-title":"Diag Microbiol Infect Dis"},{"key":"2020051911581117800_dkaa138-B7","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1006\/niox.2001.0371","article-title":"Effects of pH, nitrite and ascorbic acid on nonenzymatic nitric oxide generation and bacterial growth in urine","volume":"5","author":"Carlsson","year":"2001","journal-title":"Nitric Oxide"},{"key":"2020051911581117800_dkaa138-B8","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1067\/mda.2003.8","article-title":"The etiology of urinary tract infection: traditional and emerging pathogens","volume":"49","author":"Ronald","year":"2003","journal-title":"Dis Mon"},{"key":"2020051911581117800_dkaa138-B9","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1080\/17843286.2018.1516173","article-title":"Hypomagnesemia and hypermagnesemia","volume":"74","author":"van Laecke","year":"2019","journal-title":"Acta Clin Belg"},{"key":"2020051911581117800_dkaa138-B10","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1309\/LM9SO94ZNBHEDNTM","article-title":"Urine calcium: laboratory measurement and clinical utility","volume":"41","author":"Foley","year":"2010","journal-title":"Lab Med"},{"key":"2020051911581117800_dkaa138-B11","doi-asserted-by":"crossref","first-page":"e6017","DOI":"10.1097\/MD.0000000000006017","article-title":"Hyperthyroidism-associated hypercalcemic crisis: a case report and review of the literature","volume":"96","author":"Chen","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"2020051911581117800_dkaa138-B12","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/ki.1983.93","article-title":"The kidney and magnesium regulation","volume":"23","author":"Dirks","year":"1983","journal-title":"Kidney Int"},{"key":"2020051911581117800_dkaa138-B13","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1001\/jamasurg.2016.2310","article-title":"The American Association of Endocrine Surgeons guidelines for definitive management of primary hyperparathyroidism","volume":"151","author":"Wilhelm","year":"2016","journal-title":"JAMA Surg"},{"key":"2020051911581117800_dkaa138-B14","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.ejim.2015.05.013","article-title":"Hypermagnesemia is a strong independent risk factor for mortality in critically ill patients: results from a cross-sectional study","volume":"26","author":"Haider","year":"2015","journal-title":"Eur J Int Med"},{"key":"2020051911581117800_dkaa138-B15","doi-asserted-by":"crossref","first-page":"731.e1","DOI":"10.1016\/j.urology.2014.04.048","article-title":"The influence of urinary pH on antibiotic efficacy against bacterial uropathogens","volume":"84","author":"Yang","year":"2014","journal-title":"Urology"},{"author":"Thwaites","key":"2020051911581117800_dkaa138-B16"},{"key":"2020051911581117800_dkaa138-B17","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1128\/MMBR.21.1.46-68.1957","article-title":"The mutual effects of antimicrobial compounds and metallic cations","volume":"21","author":"Weinberg","year":"1957","journal-title":"Bacteriol Rev"},{"key":"2020051911581117800_dkaa138-B18","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1128\/AAC.16.4.434","article-title":"Effect of divalent cation concentrations on the antibiotic susceptibilities of nonfermenters other than Pseudomonas aeruginosa","volume":"16","author":"Fass","year":"1979","journal-title":"Antimicrob Agents Chemother"},{"key":"2020051911581117800_dkaa138-B19","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1128\/AAC.7.5.596","article-title":"Effect of calcium and magnesium ions on the susceptibility of Pseudomonas species to tetracycline, gentamicin, polymyxin B, and carbenicillin","volume":"7","author":"D\u2019Amato","year":"1975","journal-title":"Antimicrob Agents Chemother"},{"key":"2020051911581117800_dkaa138-B20","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0009-8981(86)90126-9","article-title":"Dependence of urine composition on the age and sex of healthy subjects","volume":"160","author":"Hesse","year":"1986","journal-title":"Clin Chim Acta"},{"year":"2016","key":"2020051911581117800_dkaa138-B21"},{"year":"2015","key":"2020051911581117800_dkaa138-B22"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/advance-article-pdf\/doi\/10.1093\/jac\/dkaa138\/33237824\/dkaa138.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jac\/advance-article-pdf\/doi\/10.1093\/jac\/dkaa138\/33237824\/dkaa138.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,19]],"date-time":"2020-05-19T20:41:31Z","timestamp":1589920891000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/advance-article\/doi\/10.1093\/jac\/dkaa138\/5840661"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,19]]},"references-count":22,"URL":"https:\/\/doi.org\/10.1093\/jac\/dkaa138","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"type":"print","value":"0305-7453"},{"type":"electronic","value":"1460-2091"}],"subject":[],"published":{"date-parts":[[2020,5,19]]},"article-number":"dkaa138"}}